Our results also revealed that FAM225A directly interacted with miR-130a-5p by luciferase reporter assay, and miR-130a-5p expression was obviously lower in HCC tissues and in sorafenib-resistant cells, confirming the role of miR-130a-5p acting as a tumor suppressor. Here, FAM225A is linked to hepatocellular carcinoma.